XML 107 R83.htm IDEA: XBRL DOCUMENT v3.24.0.1
Notes to the Balance Sheet - Summary of Financial Information Investment in Associates (Details) - EUR (€)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disclosure of associates [line items]        
Total Current Assets € 814,021,511 € 1,089,040,787    
Cash and Cash Equivalents 158,499,651 402,350,904 € 123,248,256 € 109,794,680
Non-Current Assets 1,212,289,702 1,307,891,476    
Total Current Liabilities 264,309,607 278,346,545    
thereof Financial Liabilities (excluding Accounts Payable) 1,824,607,000 2,053,071,000    
Non-Current Liabilities 1,712,952,367 1,961,176,169    
Stockholders’ Equity 49,049,239 157,409,549 244,875,943 € 621,322,017
Revenues 238,278,313 278,267,003 179,611,844  
Interest Income 18,300,000 (3,000,000) (1,700,000)  
Interest Expenses (4,661,000) (2,752,000) (2,415,000)  
Income Tax Benefit / (Expenses) (1,188,537) 168,578,523 (76,590,860)  
Consolidated Net Profit / (Loss) (189,734,199) (151,058,190) (514,460,016)  
Other Comprehensive Income (26,891,150) 62,569,010 50,546,172  
Total Comprehensive Income € (216,625,349) € (88,489,180) € (463,913,844)  
HI-Bio        
Disclosure of associates [line items]        
Level of participation of entity compared with other participating entities 12.10% 15.00%    
Total Current Assets € 16,976,000 € 12,052,000    
Cash and Cash Equivalents 15,432,000 11,220,000    
thereof Other Assets 1,544,000 833,000    
Non-Current Assets 39,849,000 31,421,000    
Total Current Liabilities 12,095,000 10,943,000    
thereof Financial Liabilities (excluding Accounts Payable) 712,000 10,334,000    
thereof Other Financial Liabilities 11,383,000 609,000    
Non-Current Liabilities 5,839,000 11,358,000    
Stockholders’ Equity 38,890,000 21,173,000    
Group Share in Equity (2023: 12.1%; 2022: 15.0%) 4,694,000 3,176,000    
Revenues 0 0    
Interest Income 1,188,000 (5,000)    
Depreciation and Amortization (185,000) (58,000)    
Interest Expenses 0 (10,000)    
Income Tax Benefit / (Expenses) 0 0    
Consolidated Net Profit / (Loss) (54,312,000) (28,700,000)    
Other Comprehensive Income 0 0    
Total Comprehensive Income (54,312,000) (28,700,000)    
Dividends Received € 0 € 0